Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Antonelli

Showing results (191-200 of 199) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 199 results.
Scientific Reports|May 25, 2019
Author Correction: Differential expression of CXCR3 and CCR6 on CD4<sup>+</sup> T-lymphocytes with distinct memory phenotypes characterizes tuberculosis-associated immune reconstitution inflammatory syndromePaulo S Silveira-Mattos, Gopalan Narendran, Kevan Akrami, et al.
Scientific Reports|February 8, 2019
Differential expression of CXCR3 and CCR6 on CD4<sup>+</sup> T-lymphocytes with distinct memory phenotypes characterizes tuberculosis-associated immune reconstitution inflammatory syndromePaulo S Silveira-Mattos, Gopalan Narendran, Kevan Akrami, et al.
Journal of Leukocyte Biology|May 19, 2020
Circulating inflammatory mediators as biomarkers of ocular toxoplasmosis in acute and in chronic infectionAna Pmp Marino, Luara I Dos Santos, Priscilla M Henriques, et al.
The Journal of Infectious Diseases|October 27, 2012
Association of a NOD2 gene polymorphism and T-helper 17 cells with presumed ocular toxoplasmosisMíriam S Dutra, Samantha R Béla, Alba L Peixoto-Rangel, et al.
Plos Pathogens|October 3, 2014
Mycobacterial antigen driven activation of CD14++CD16- monocytes is a predictor of tuberculosis-associated immune reconstitution inflammatory syndromeBruno B Andrade, Amrit Singh, Gopalan Narendran, et al.
JCO Precision Oncology|January 20, 2022
Palbociclib in Patients With Non-Small-Cell Lung Cancer With <i>CDKN2A</i> Alterations: Results From the Targeted Agent and Profiling Utilization Registry StudyEugene R Ahn, Pam K Mangat, Elizabeth Garrett-Mayer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2021
Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) StudyAjjai S Alva, Pam K Mangat, Elizabeth Garrett-Mayer, et al.
Nature Communications|August 17, 2022
Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion proteinJulia T Castro, Patrick Azevedo, Marcílio J Fumagalli, et al.
Human Vaccines & Immunotherapeutics|September 12, 2015
Booster dose after 10 years is recommended following 17DD-YF primary vaccinationAna Carolina Campi-Azevedo, Christiane Costa-Pereira, Lis R Antonelli, et al.
Pageof 20

Showing results (191-200 of 199) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 199 results.
Scientific Reports|May 25, 2019
Author Correction: Differential expression of CXCR3 and CCR6 on CD4<sup>+</sup> T-lymphocytes with distinct memory phenotypes characterizes tuberculosis-associated immune reconstitution inflammatory syndromePaulo S Silveira-Mattos, Gopalan Narendran, Kevan Akrami, et al.
Scientific Reports|February 8, 2019
Differential expression of CXCR3 and CCR6 on CD4<sup>+</sup> T-lymphocytes with distinct memory phenotypes characterizes tuberculosis-associated immune reconstitution inflammatory syndromePaulo S Silveira-Mattos, Gopalan Narendran, Kevan Akrami, et al.
Journal of Leukocyte Biology|May 19, 2020
Circulating inflammatory mediators as biomarkers of ocular toxoplasmosis in acute and in chronic infectionAna Pmp Marino, Luara I Dos Santos, Priscilla M Henriques, et al.
The Journal of Infectious Diseases|October 27, 2012
Association of a NOD2 gene polymorphism and T-helper 17 cells with presumed ocular toxoplasmosisMíriam S Dutra, Samantha R Béla, Alba L Peixoto-Rangel, et al.
Plos Pathogens|October 3, 2014
Mycobacterial antigen driven activation of CD14++CD16- monocytes is a predictor of tuberculosis-associated immune reconstitution inflammatory syndromeBruno B Andrade, Amrit Singh, Gopalan Narendran, et al.
JCO Precision Oncology|January 20, 2022
Palbociclib in Patients With Non-Small-Cell Lung Cancer With <i>CDKN2A</i> Alterations: Results From the Targeted Agent and Profiling Utilization Registry StudyEugene R Ahn, Pam K Mangat, Elizabeth Garrett-Mayer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 12, 2021
Pembrolizumab in Patients With Metastatic Breast Cancer With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) StudyAjjai S Alva, Pam K Mangat, Elizabeth Garrett-Mayer, et al.
Nature Communications|August 17, 2022
Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion proteinJulia T Castro, Patrick Azevedo, Marcílio J Fumagalli, et al.
Human Vaccines & Immunotherapeutics|September 12, 2015
Booster dose after 10 years is recommended following 17DD-YF primary vaccinationAna Carolina Campi-Azevedo, Christiane Costa-Pereira, Lis R Antonelli, et al.
Pageof 20